Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Sinopharm Group Co., Ltd.
  6. News
  7. Summary
    1099   CNE100000FN7

SINOPHARM GROUP CO., LTD.

(1099)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sinopharm : Nine-Month Net Profit Rose 7.9%

10/22/2020 | 08:13pm EDT

By Justina Lee

Sinopharm Group Co.'s net profit for the nine months ended September rose 7.9% from a year earlier, helped by higher total operating revenue.

The drug seller posted net profit of 4.96 billion yuan ($742 million) for the period, compared with 4.60 billion yuan a year earlier.

Total operating revenue rose 4.8% to CN327.61 billion from CNY312.69 billion a year ago, said the Chinese company, which mainly engages in the distribution of pharmaceutical and healthcare products.

Write to Justina Lee at justina.lee@wsj.com

(END) Dow Jones Newswires

10-22-20 2012ET

Stocks mentioned in the article
ChangeLast1st jan.
SINOPHARM GROUP CO., LTD. -4.25% 22.55 End-of-day quote.19.57%
UNITED STATES DOLLAR (B) / CHINESE YUAN IN HONG KONG (USD/CNH) 0.27% 6.47314 Delayed Quote.-0.60%
All news about SINOPHARM GROUP CO., LTD.
06/18ASTRAZENECAá : Argentine lab makes first half million doses of Russian COVID-19 ..
RE
06/15SINOPHARM GROUP CO., LTD. : Ex-dividend day for final dividend
FA
06/09China to study using CanSinoBIO COVID shots as a booster
RE
06/08Boyu, Sinopharm among bidders shortlisted for Mundipharma China - sources
RE
06/04Who senior adviser says having "very positive" conversations with sinovac an..
RE
06/02MARKET CHATTER : Sinopharm Can Supply Over 1 Billion COVID-19 Vaccines in H2, Ch..
MT
06/02Bahrain, Facing a Covid Surge, Starts Giving Pfizer Boosters to Recipients of..
DJ
06/02Bahrain Residents Who Are Over 50, Obese, Have Chronic Illnesses Urged To Get..
RE
06/02Bahrain residents who are over 50, obese, have chronic illnesses urged to get..
RE
06/01SINOPHARMá : WHO Grants Emergency-Use Approval to Sinovac's COVID-19 Vaccine
MT
More news
Financials
Sales 2021 527 B 81 525 M 81 525 M
Net income 2021 8 067 M 1 248 M 1 248 M
Net Debt 2021 16 870 M 2 609 M 2 609 M
P/E ratio 2021 7,25x
Yield 2021 4,03%
Capitalization 59 401 M 9 205 M 9 188 M
EV / Sales 2021 0,14x
EV / Sales 2022 0,13x
Nbr of Employees 108 316
Free-Float 43,0%
Chart SINOPHARM GROUP CO., LTD.
Duration : Period :
Sinopharm Group Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SINOPHARM GROUP CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Average target price 23,87 CNY
Last Close Price 18,74 CNY
Spread / Highest target 58,7%
Spread / Average Target 27,4%
Spread / Lowest Target -8,40%
EPS Revisions
Managers and Directors
NameTitle
Yong Liu President & Executive Director
Xiao Juan Li Chief Financial Officer
Fang Yao Chairman-Supervisory Board
Qing Ming Yu Chairman
Wu Ping Tao Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
SINOPHARM GROUP CO., LTD.19.57%9 065
JD HEALTH INTERNATIONAL INC.-28.33%44 096
WALGREENS BOOTS ALLIANCE, INC.27.48%43 946
MCKESSON CORPORATION6.31%28 596
CARDINAL HEALTH, INC.4.65%16 263
HUADONG MEDICINE CO., LTD62.27%11 687